Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Total Non-Current Liabilities (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Total Non-Current Liabilities for 6 consecutive years, with $3.6 million as the latest value for Q3 2018.

  • Quarterly Total Non-Current Liabilities changed 0.33% to $3.6 million in Q3 2018 from the year-ago period, while the trailing twelve-month figure was $3.6 million through Sep 2018, changed 0.33% year-over-year, with the annual reading at $3.1 million for FY2017, 47.97% down from the prior year.
  • Total Non-Current Liabilities hit $3.6 million in Q3 2018 for Armata Pharmaceuticals, up from $3.2 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $69.5 million in Q1 2014 to a low of $2.9 million in Q1 2018.
  • Historically, Total Non-Current Liabilities has averaged $13.9 million across 5 years, with a median of $6.0 million in 2016.
  • Biggest YoY gain for Total Non-Current Liabilities was 11.08% in 2016; the steepest drop was 76.66% in 2016.
  • Year by year, Total Non-Current Liabilities stood at $17.4 million in 2014, then crashed by 68.96% to $5.4 million in 2015, then grew by 11.08% to $6.0 million in 2016, then crashed by 47.97% to $3.1 million in 2017, then increased by 15.96% to $3.6 million in 2018.
  • Business Quant data shows Total Non-Current Liabilities for ARMP at $3.6 million in Q3 2018, $3.2 million in Q2 2018, and $2.9 million in Q1 2018.